{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:58:01Z","timestamp":1753891081874,"version":"3.41.2"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T00:00:00Z","timestamp":1665014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018531","name":"Major Science and Technology Projects in Yunnan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018531","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Despite the surge in the number of antibiotics used to treat preclinical osteomyelitis (OM), their efficacy remains inadequately assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To establish network comparisons on the efficacy of antibiotic regimens on OM in animal studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>PubMed, Embase, Web of Science, and The Cochrane Library were searched from inception to March 2022 for relevant articles. Odds ratios (ORs) were generated for dichotomous variants, and the standard mean difference (SMD) was calculated for constant variables. The predominant outcomes were the effective rate of sterility, also known as sterility rates, as well as the bacterial counts at the end of the experiments and antibiotic concentrations in serum or bone. All the network meta-analyses were performed using STATA MP 16.0. This study was registered in the International Prospective Register of Systematic Reviews (PROSPERO; no. CRD42022316544).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 28 eligible studies with 1,488 animals were included for data analysis, including 13 antibiotic regimens. Regarding the effective rate of sterility, glycopeptides (GLY), linezolid (LIN), rifampicin (RIF)+\u03b2-Lactam, and \u03b2-Lactam showed significant efficacy compared with placebo (OR ranging from 0.01 to 0.08). For radiological grade, only RIF+GLY (SMD: \u22125.92, 95%CI: \u221211.65 to \u22120.19) showed significant efficacy compared with placebo. As for reducing bacteria count, fosfomycin (FOS), tigecycline (TIG), GLY, LIN, RIF, RIF+\u03b2-Lactam, RIF+GLY, aminoglycosides (AMI), and clindamycin (CLI) showed significant efficacy compared with placebo (SMD ranging from \u22126.32 to \u22122.62). Moreover, the bone concentrations of GLY were higher 1 h after administration and the higher blood concentrations were higher after 1 h and 4 h compared with the other antibiotics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Multiple antibiotic regimens showed significant efficacy in animals with OM, including increasing effective rates of sterility, reducing bacterial counts, and lowering radiological scores. Among them, RIF+GLY was the most promising treatment regimen owing to its optimal efficacy. Based on the preclinical studies included in our meta-analysis, head-to-head clinical randomized controlled trials are required to confirm these findings in humans.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.975666","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T12:57:52Z","timestamp":1665061072000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparing the efficacy of different antibiotic regimens on osteomyelitis: A network meta-analysis of animal studies"],"prefix":"10.3389","volume":"9","author":[{"given":"Xiangwen","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yipeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haonan","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0140-6736(04)16727-5","article-title":"Osteomyelitis","volume":"364","author":"Lew","year":"2004","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1056\/NEJMra035415","article-title":"Treatment of infections associated with surgical implants","volume":"350","author":"Darouiche","year":"2004","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1017\/S0950268807008850","article-title":"Epidemiology of vertebral osteomyelitis (VO) in France: analysis of hospital-discharge data 2002-2003","volume":"136","author":"Grammatico","year":"2008","journal-title":"Epidemiol Infect."},{"key":"B4","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1128\/AAC.42.4.895","article-title":"Impact of bacterial biofilm formation on in vitro and in vivo activities of antibiotics","volume":"42","author":"Schwank","year":"1998","journal-title":"Antimicrob Agents Chemother."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1001\/jama.279.19.1537","article-title":"Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group","volume":"279","author":"Zimmerli","year":"1998","journal-title":"Jama."},{"key":"B6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/jac\/39.2.235","article-title":"Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin","volume":"39","author":"Drancourt","year":"1997","journal-title":"J Antimicrob Chemother."},{"key":"B7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s13018-020-01877-2","article-title":"Rifampin combination therapy in staphylococcal prosthetic joint infections: a randomized controlled trial","volume":"15","author":"Karlsen","year":"2020","journal-title":"J Orthop Surg Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE's risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med Res Methodol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"Bmj."},{"key":"B10","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ."},{"key":"B11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/infdis\/132.5.493","article-title":"Experimental osteomyelitis. IV Therapeutic trials with rifampin alone and in combination with gentamicin, sisomicin, and cephalothin","volume":"132","author":"Norden","year":"1975","journal-title":"J Infect Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1128\/AAC.17.4.591","article-title":"Treatment of experimental staphylococcal osteomyelitis with rifampin and trimethoprim, alone and in combination","volume":"17","author":"Norden","year":"1980","journal-title":"Antimicrob Agents Chemother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"S491","DOI":"10.1093\/clinids\/5.Supplement_3.S491","article-title":"Experimental chronic staphylococcal osteomyelitis in rabbits: treatment with rifampin alone and in combination with other antimicrobial agents","volume":"5","author":"Norden","year":"1983","journal-title":"Rev Infect Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/infdis\/147.2.352","article-title":"Treatment of experimental chronic osteomyelitis due to staphylococcus aureus with vancomycin and rifampin","volume":"147","author":"Norden","year":"1983","journal-title":"J Infect Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1159\/000238267","article-title":"Treatment of experimental chronic osteomyelitis caused by Morganella morganii with mezlocillin and cloxacillin","volume":"30","author":"Norden","year":"1984","journal-title":"Chemotherapy."},{"key":"B16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1128\/AAC.31.2.259","article-title":"Comparative evaluation of A-56619, A-56620, and nafcillin in the treatment of experimental Staphylococcus aureus osteomyelitis","volume":"31","author":"Mader","year":"1987","journal-title":"Antimicrob Agents Chemother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1128\/AAC.33.5.689","article-title":"Comparative evaluation of daptomycin (LY146032) and vancomycin in the treatment of experimental methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits","volume":"33","author":"Mader","year":"1989","journal-title":"Antimicrob Agents Chemother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/00003086-199902000-00026","article-title":"Oral rifampin plus azithromycin or clarithromycin to treat osteomyelitis in rabbits","volume":"359","author":"Shirtliff","year":"1999","journal-title":"Clin Orthop Relat Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/jac\/48.2.253","article-title":"Comparative evaluation of oral levofloxacin and parenteral nafcillin in the treatment of experimental methicillin-susceptible Staphylococcus aureus osteomyelitis in rabbits","volume":"48","author":"Shirtliff","year":"2001","journal-title":"J Antimicrob Chemother."},{"key":"B20","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/jac\/dki109","article-title":"Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model","volume":"55","author":"Yin","year":"2005","journal-title":"J Antimicrob Chemother."},{"key":"B21","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ijantimicag.2010.07.008","article-title":"Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis","volume":"36","author":"Lefebvre","year":"2010","journal-title":"Int J Antimicrob Agents."},{"key":"B22","doi-asserted-by":"publisher","first-page":"6291","DOI":"10.1128\/AAC.00926-12","article-title":"Ceftobiprole efficacy in vitro against Panton-Valentine leukocidin production and in vivo against community-associated methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits","volume":"56","author":"Saleh-Mghir","year":"2012","journal-title":"Antimicrob Agents Chemother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1093\/jac\/dkz257","article-title":"Efficacy of colistin alone and in various combinations for the treatment of experimental osteomyelitis due to carbapenemase-producing Klebsiella pneumoniae","volume":"74","author":"Cr\u00e9mieux","year":"2019","journal-title":"J Antimicrob Chemother."},{"key":"B24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1179\/joc.2008.20.1.53","article-title":"Comparison of the efficacy of tigecycline and teicoplanin in an experimental methicillin-resistant Staphylococcus aureus osteomyelitis model","volume":"20","author":"Kandemir","year":"2008","journal-title":"J Chemother."},{"key":"B25","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.1128\/AAC.00584-11","article-title":"Daptomycin, fosfomycin, or both for treatment of methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model","volume":"55","author":"Poeppl","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"key":"B26","doi-asserted-by":"publisher","first-page":"5111","DOI":"10.1128\/AAC.02720-13","article-title":"Efficacy of fosfomycin compared to vancomycin in treatment of implant-associated chronic methicillin-resistant Staphylococcus aureus osteomyelitis in rats","volume":"58","author":"Poeppl","year":"2014","journal-title":"Antimicrob Agents Chemother."},{"key":"B27","doi-asserted-by":"publisher","first-page":"9661","DOI":"10.1038\/s41598-018-28006-8","article-title":"Dalbavancin for treatment of implant-related methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model","volume":"8","author":"Kussmann","year":"2018","journal-title":"Sci Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1128\/AAC.01235-19","article-title":"Exebacase in Addition to Daptomycin Is More Active than Daptomycin or Exebacase Alone in Methicillin-Resistant Staphylococcus aureus Osteomyelitis in Rats","author":"Karau","year":"2019","journal-title":"Antimicrob Agents Chemother."},{"key":"B29","first-page":"420","article-title":"Therapeutic Effects of Terazolamide on Methicillin-Resistant Staphylococcus Epidermidis Implant Associated Osteomyelitis","volume":"21","author":"Lou","year":"2021","journal-title":"Zhongguo Yi Yuan Yong Yao Ping Jia Yu Fen Xi."},{"key":"B30","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1006\/jsre.1998.5416","article-title":"Application of a rat osteomyelitis model to compare in vivo and in vitro the antibiotic efficacy against bacteria with high capacity to form biofilms","volume":"79","author":"Gracia","year":"1998","journal-title":"J Surg Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/17453670610046082","article-title":"Moxifloxacin superior to vancomycin for treatment of bone infections\u2013a study in rats","volume":"77","author":"Kalteis","year":"2006","journal-title":"Acta Orthop."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1128\/AAC.00740-10","article-title":"Treatment with linezolid or vancomycin in combination with rifampin is effective in an animal model of methicillin-resistant Staphylococcus aureus foreign body osteomyelitis","volume":"55","author":"Vergidis","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"key":"B33","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.jinf.2014.12.016","article-title":"Comparative activities of vancomycin, tigecycline and rifampin in a rat model of methicillin-resistant Staphylococcus aureus osteomyelitis","volume":"70","author":"Vergidis","year":"2015","journal-title":"J Infect."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e01822","DOI":"10.1128\/AAC.01822-16","article-title":"Rifampin-Based Combination Therapy Is Active in Foreign-Body Osteomyelitis after Prior Rifampin Monotherapy","volume":"61","author":"Brinkman","year":"2017","journal-title":"Antimicrob Agents Chemother."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1093\/infdis\/jiaa401","article-title":"Novel use of rifabutin and rifapentine to treat methicillin-resistant staphylococcus aureus in a rat model of foreign body osteomyelitis","volume":"222","author":"Karau","year":"2020","journal-title":"J Infect Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1128\/AAC.34.6.1014","article-title":"Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis","volume":"34","author":"Dworkin","year":"1990","journal-title":"Antimicrob Agents Chemother."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1128\/AAC.36.12.2693","article-title":"Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin","volume":"36","author":"O'Reilly","year":"1992","journal-title":"Antimicrob Agents Chemother."},{"key":"B38","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/BF01967482","article-title":"Treatment of chronic experimental Staphylococcus aureus osteomyelitis with LY146032 and vancomycin","volume":"8","author":"Luu","year":"1989","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e01644","DOI":"10.1128\/AAC.01644-16","article-title":"Activity of tedizolid in methicillin-resistant staphylococcus epidermidis experimental foreign body-associated osteomyelitis","volume":"61","author":"Park","year":"2017","journal-title":"Antimicrob Agents Chemother."},{"key":"B40","doi-asserted-by":"publisher","first-page":"E297","DOI":"10.1097\/BRS.0b013e31816f6c22","article-title":"Fluoroquinolones versus beta-lactam based regimens for the treatment of osteomyelitis: a meta-analysis of randomized controlled trials","volume":"33","author":"Karamanis","year":"2008","journal-title":"Spine."},{"key":"B41","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Health Syst Pharm."},{"key":"B42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J Basic Clin Pharm."},{"key":"B43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1258\/002367795780740393","article-title":"Antibiotic therapeutics in laboratory animals","volume":"29","author":"Morris","year":"1995","journal-title":"Lab Anim."},{"key":"B44","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1046\/j.1198-743x.2001.00295.x","article-title":"Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters","volume":"7","author":"Jacobs","year":"2001","journal-title":"Clin Microbiol Infect."},{"key":"B45","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41579-022-00686-0","article-title":"Skeletal infections: microbial pathogenesis, immunity and clinical management","volume":"20","author":"Masters","year":"2022","journal-title":"Nat Rev Microbiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01652176.2021.2022244","article-title":"Microbiological aspects of osteomyelitis in veterinary medicine: drawing parallels to the infection in human medicine","volume":"42","author":"Gonz\u00e1lez-Mart\u00edn","year":"2022","journal-title":"Vet Q."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1007\/s00253-022-11837-x","article-title":"Involvement of the SCO3366 efflux pump from S. coelicolor in rifampicin resistance and its regulation by a TetR regulator","volume":"106","author":"Nag","year":"2022","journal-title":"Appl Microbiol Biotechnol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1086\/318840","article-title":"Outer membrane channels and active transporters for the uptake of antibiotics","volume":"183","author":"Braun","year":"2001","journal-title":"J Infect Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.bbamem.2015.11.004","article-title":"Gram-positive bacterial cell envelopes: The impact on the activity of antimicrobial peptides","volume":"1858","author":"Malanovic","year":"2016","journal-title":"Biochim Biophys Acta."},{"key":"B50","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.micpath.2015.11.031","article-title":"Antibacterial efficacy of rifampin loaded solid lipid nanoparticles against Staphylococcus epidermidis biofilm","volume":"93","author":"Fazly Bazzaz","year":"2016","journal-title":"Microb Pathog."},{"key":"B51","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1126\/science.aaj2191","article-title":"Antibiotic tolerance facilitates the evolution of resistance","volume":"355","author":"Levin-Reisman","year":"2017","journal-title":"Science."},{"key":"B52","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1126\/science.aay3041","article-title":"Effect of tolerance on the evolution of antibiotic resistance under drug combinations","volume":"367","author":"Liu","year":"2020","journal-title":"Science."},{"key":"B53","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1592\/phco.30.1.80","article-title":"A comparative review of the lipoglycopeptides: oritavancin, dalbavancin, and telavancin","volume":"30","author":"Guskey","year":"2010","journal-title":"Pharmacotherapy."},{"key":"B54","doi-asserted-by":"publisher","first-page":"ftw019","DOI":"10.1093\/femspd\/ftw019","article-title":"Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro","volume":"74","author":"J\u00f8rgensen","year":"2016","journal-title":"Pathog Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1345\/aph.1Q331","article-title":"Successful treatment of polymicrobial calcaneal osteomyelitis with telavancin, rifampin, and meropenem","volume":"46","author":"Brinkman","year":"2012","journal-title":"Ann Pharmacother."},{"key":"B56","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.diagmicrobio.2007.06.023","article-title":"Activity of ceftobiprole against community-associated methicillin-resistant Staphylococcus aureus isolates recently recovered from US military trainees","volume":"59","author":"Yun","year":"2007","journal-title":"Diagn Microbiol Infect Dis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1128\/AAC.00257-08","article-title":"Activities of ceftobiprole, linezolid, vancomycin, and daptomycin against community-associated and hospital-associated methicillin-resistant Staphylococcus aureus","volume":"52","author":"Leonard","year":"2008","journal-title":"Antimicrob Agents Chemother."},{"key":"B58","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1139\/m92-102","article-title":"Eradication of biofilm cells of Staphylococcus aureus with tobramycin and cephalexin","volume":"38","author":"Anwar","year":"1992","journal-title":"Can J Microbiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1080\/14740338.2018.1462334","article-title":"An update on adverse drug reactions related to \u03b2-lactam antibiotics","volume":"17","author":"Vardakas","year":"2018","journal-title":"Expert Opin Drug Saf."},{"key":"B60","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1517\/17425255.2013.788150","article-title":"Pharmacokinetic and pharmacodynamics evaluation of ceftobiprole medocaril for the treatment of hospital-acquired pneumonia","volume":"9","author":"Lagac\u00e9-Wiens","year":"2013","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/jac\/dkp230","article-title":"High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection","volume":"64","author":"Schintler","year":"2009","journal-title":"J Antimicrob Chemother."},{"key":"B62","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1473-3099(09)70325-1","article-title":"Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review","volume":"10","author":"Falagas","year":"2010","journal-title":"Lancet Infect Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijantimicag.2010.09.002","article-title":"Adverse events associated with intravenous fosfomycin","volume":"37","author":"Florent","year":"2011","journal-title":"Int J Antimicrob Agents."},{"key":"B64","doi-asserted-by":"publisher","first-page":"114066","DOI":"10.1016\/j.ejmech.2021.114066","article-title":"Tuberculosis drug discovery: Progression and future interventions in the wake of emerging resistance","volume":"229","author":"Perveen","year":"2022","journal-title":"Eur J Med Chem."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1111\/cts.13281","article-title":"A literature review of liver function test elevations in rifampin drug-drug interaction studies","volume":"15","author":"Ibrahim","year":"2022","journal-title":"Clin Transl Sci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1517\/14740338.2012.632631","article-title":"The efficacy and safety of antibiotic combination therapy for infections caused by Gram-positive and Gram-negative organisms","volume":"11","author":"Hagihara","year":"2012","journal-title":"Expert Opin Drug Saf."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.2165\/0019053-200826120-00005","article-title":"Management and prevention of diabetic foot ulcers and infections: a health economic review","volume":"26","author":"Chow","year":"2008","journal-title":"Pharmacoeconomics."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1093\/cid\/ciw665","article-title":"A randomized study evaluating oral fusidic acid (CEM-102) in combination with oral rifampin compared with standard-of-care antibiotics for treatment of prosthetic joint infections: a newly identified drug-drug interaction","volume":"63","author":"Pushkin","year":"2016","journal-title":"Clin Infect Dis."},{"key":"B69","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1517\/14740338.5.2.231","article-title":"Adverse reactions to first-line antituberculosis drugs","volume":"5","author":"Forget","year":"2006","journal-title":"Expert Opin Drug Saf."},{"key":"B70","doi-asserted-by":"publisher","first-page":"196","DOI":"10.22203\/eCM.v027a15","article-title":"A systematic review of animal models for Staphylococcus aureus osteomyelitis","volume":"27","author":"Reizner","year":"2014","journal-title":"Eur Cell Mater."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1002\/jor.24689","article-title":"Therapeutics and delivery vehicles for local treatment of osteomyelitis","volume":"38","author":"Cobb","year":"2020","journal-title":"J Orthop Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1002\/jor.23505","article-title":"Novel porcine model of implant-associated osteomyelitis: A comprehensive analysis of local, regional, and systemic response","volume":"35","author":"Jensen","year":"2017","journal-title":"J Orthop Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/jsap.12644","article-title":"Epidemiology of bacterial conjunctivitis in chinchillas (Chinchilla lanigera): 49 cases (2005 to 2015)","volume":"58","author":"Ozawa","year":"2017","journal-title":"J Small Anim Pract."},{"key":"B74","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1210\/endo.139.2.5751","article-title":"Interspecies differences in bone composition, density, and quality: potential implications for in vivo bone research","volume":"139","author":"Aerssens","year":"1998","journal-title":"Endocrinology."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.975666\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T12:57:59Z","timestamp":1665061079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.975666\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,6]]},"references-count":74,"alternative-id":["10.3389\/fmed.2022.975666"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.975666","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2022,10,6]]},"article-number":"975666"}}